CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522214851
- Phone
- 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,244,783
- in 2 filings, $3.2M under 10b5-1 plans
Net −$3,244,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-28 | Tyagarajan Seshu See Remarks | Grant or award | +73,684 | 73,684 | ||
| 2022-10-13 | Aguilar-Cordova Estuardo Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2022-10-13 | Martell Christopher Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2022-10-13 | Nguyen Diem Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2022-10-13 | Benz Edward J. JR Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2022-10-13 | Manning Paul B Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2022-09-21 | Amello Jason Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 | ||
| 2022-09-12 | Nichols William Garrett Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-08-08 | Gaeta Renee Director | Grant or award · Stock Option (Right to Buy) | +28,480 | 28,480 | ||
| 2022-08-08 | Nabel Gary J. Director | Grant or award · Stock Option (Right to Buy) | +28,480 | 28,480 | ||
| 2022-08-08 | PAPA JOSEPH C Director | Grant or award · Stock Option (Right to Buy) | +28,480 | 28,480 | ||
| 2022-05-06 | Aguilar Laura K. 10% owner | Option exercise | +171,335 | $1.46 | $250K | 1,102,374 |
| 2022-05-06 | Aguilar Laura K. 10% owner | Shares withheld for taxes | −68,534 | $3.65 | $250K | 1,033,840 |
| 2022-05-06 | Aguilar Laura K. 10% owner | Option exercise · Stock Option (Right to Buy) | −17,901 | 0 | ||
| 2022-05-06 | Aguilar Laura K. 10% owner | Option exercise · Stock Option (Right to Buy) | −76,717 | 0 | ||
| 2022-05-06 | Aguilar Laura K. 10% owner | Option exercise · Stock Option (Right to Buy) | −76,717 | 0 | ||
| 2022-05-06 | Aguilar-Cordova Estuardo Director | Option exercise | +135,183 | $1.46 | $197K | 1,151,106 |
| 2022-05-06 | Aguilar-Cordova Estuardo Director | Shares withheld for taxes | −54,074 | $3.65 | $197K | 1,097,032 |
| 2022-05-06 | Aguilar-Cordova Estuardo Director | Option exercise · Stock Option (Right to Buy) | −12,205 | 0 | ||
| 2022-05-06 | Aguilar-Cordova Estuardo Director | Option exercise · Stock Option (Right to Buy) | −76,717 | 0 |
Page 11 of 13 · 249 trades